ACB
Aurora Cannabis Inc.
Price Chart
Latest Quote
$2.63
+0.05 (+1.94%)
Current Price
| Previous Close | $2.58 |
| Open | $2.56 |
| Day High | $2.67 |
| Day Low | $2.56 |
| Volume | 1,240,318 |
Stock Information
Note: Financial values converted from CAD to USD
| Shares Outstanding | 61.94M |
| Total Debt | $17.02M |
| Cash Equivalents | $83.38M |
| Revenue | $228.67M |
| Net Income | $-41.81M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $162.91M |
| EPS (TTM) | $-0.73 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $69.86M |
| Sales | $228.67M |
| Income | $-41.81M |
| Book/sh | $6.18 |
| Cash/sh | $1.89 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 2.41 |
| Current Ratio | 5.94 |
| Debt/Eq | 4.66 |
Returns & Margins
| ROA | -4.01% |
| ROE | -10.46% |
| Gross Margin | 42.62% |
| Operating Margin | -26.39% |
| Profit Margin | -42.41% |
Ownership
| Insider Ownership | 1.27% |
| Institutional Ownership | 9.70% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -23.91 |
| P/S | 0.51 |
| P/B | 0.43 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.75 |
| SMA50 | $3.12 |
| SMA200 | $3.94 |
| RSI | 32.76 |
| ATR | 0.0969 |
| Shares Float | 61.54M |
| Short Ratio | 6.64 |
| Volatility | 1.35 |
| Rel Volume | 1.04 |
Performance History
| Week | -2.95% |
| Month | -12.33% |
| Quarter | -27.15% |
| 6 Months | -38.26% |
| YTD | -39.40% |
| Year | -41.29% |
| 3 Years | -53.12% |
| 5 Years | -96.81% |
| 10 Years | -93.13% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-07-17 | $2.63 | 1,259,800 |
| 2026-07-16 | $2.58 | 1,367,700 |
| 2026-07-15 | $2.66 | 874,300 |
| 2026-07-14 | $2.66 | 1,092,300 |
| 2026-07-13 | $2.67 | 1,054,900 |
| 2026-07-10 | $2.71 | 941,000 |
| 2026-07-09 | $2.70 | 1,437,200 |
| 2026-07-08 | $2.68 | 1,365,600 |
| 2026-07-07 | $2.67 | 972,900 |
| 2026-07-06 | $2.71 | 1,621,700 |
| 2026-07-02 | $2.84 | 1,379,100 |
| 2026-07-01 | $2.81 | 1,008,700 |
| 2026-06-30 | $2.79 | 1,492,600 |
| 2026-06-29 | $2.88 | 956,600 |
| 2026-06-26 | $2.83 | 1,281,800 |
| 2026-06-25 | $2.76 | 982,200 |
| 2026-06-24 | $2.83 | 1,043,100 |
| 2026-06-23 | $2.85 | 1,156,400 |
| 2026-06-22 | $2.87 | 1,416,000 |
| 2026-06-18 | $2.93 | 1,608,600 |
About Aurora Cannabis Inc.
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty's, Whistler, and WMMC. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.
đ° Latest News
ACB Stock Down 28% in Three Months: Time to Buy the Dip or Cash Out?
Zacks âĸ 2026-07-15T12:49:00Z
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Market Exclusive âĸ 2026-07-13T20:01:26ZVFF Stock Loses 27% in Three Months: Time to Invest or Exit?
Zacks âĸ 2026-07-08T13:49:00Z
TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell?
Zacks âĸ 2026-07-02T12:24:00Z
CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?
Zacks âĸ 2026-06-24T12:24:00Z
Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge â Quarterly Update Report
Exec Edge âĸ 2026-06-15T22:37:30Z
Aurora Cannabis Generates 55% Revenue Outside Canada as Medical Sales Surge â Downloadable Quarterly Update Report
Exec Edge âĸ 2026-06-15T22:36:18ZAurora Q4 Earnings Call Flags Reset Year as Canada Pressure Weighs
Zacks âĸ 2026-06-12T13:20:00Z
Aurora (ACB) Q4 2026 Earnings Transcript
Motley Fool âĸ 2026-06-11T20:14:26Z
Aurora Cannabis Inc (ACB) Q4 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...
GuruFocus.com âĸ 2026-06-11T19:00:25Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $123,532,049 | $69,991,174 | $83,353,262 | $110,358,571 |
| Cost Of Revenue | $130,918,421 | $76,838,052 | $98,153,763 | $142,427,866 |
| Total Revenue | $228,176,823 | $205,627,678 | $191,909,723 | $157,534,412 |
| Operating Revenue | $243,714,680 | $227,653,699 | $212,936,470 | $180,284,266 |
| Expenses | ||||
| Interest Expense | $1,287,526 | $1,790,010 | $9,820,501 | $51,111,728 |
| Total Expenses | $261,387,738 | $198,201,449 | $214,011,188 | $313,670,979 |
| Other Income Expense | $-9,893,098 | $9,296,665 | $-18,224,652 | $-1,020,226,757 |
| Other Non Operating Income Expenses | $512,448 | $1,493,929 | $1,115,287 | $-1,590,725 |
| Net Non Operating Interest Income Expense | $2,873,980 | $5,550,811 | $-696,075 | $-47,903,944 |
| Interest Expense Non Operating | $1,287,526 | $1,790,010 | $9,820,501 | $51,111,728 |
| Operating Expense | $130,469,317 | $121,363,397 | $115,857,425 | $171,243,114 |
| Other Operating Expenses | $1,405,674 | $2,444,805 | $-6,207,741 | $-5,256,153 |
| Selling And Marketing Expense | $42,448,506 | $39,978,079 | $36,946,093 | $44,145,279 |
| General And Administrative Expense | $81,037,992 | $74,200,367 | $74,050,191 | $90,368,109 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-41,721,114 | $19,252,395 | $-40,627,891 | $-1,222,490,782 |
| Net Interest Income | $2,873,980 | $5,550,811 | $-696,075 | $-47,903,944 |
| Interest Income | $4,161,507 | $7,340,821 | $9,124,425 | $3,207,784 |
| Normalized Income | $-35,477,787 | $12,508,059 | $-21,473,846 | $-205,330,904 |
| Net Income From Continuing And Discontinued Operation | $-96,770,153 | $1,132,368 | $-49,341,646 | $-1,222,490,782 |
| Total Operating Income As Reported | $130,469,317 | $121,363,397 | $-32,099,899 | $-164,730,039 |
| Net Income Common Stockholders | $-96,770,153 | $1,132,368 | $-49,341,646 | $-1,222,490,782 |
| Net Income | $-96,770,153 | $1,132,368 | $-49,341,646 | $-1,222,490,782 |
| Net Income Including Noncontrolling Interests | $-96,770,153 | $1,132,368 | $-49,341,646 | $-1,222,743,447 |
| Net Income Discontinuous Operations | $-55,049,038 | $-18,120,027 | $-8,713,755 | $0 |
| Net Income Continuous Operations | $-41,721,114 | $19,252,395 | $-40,627,891 | $-1,222,743,447 |
| Pretax Income | $-40,230,032 | $22,273,704 | $-41,022,192 | $-1,224,267,269 |
| Special Income Charges | $-11,359,981 | $-495,367 | $-27,370,429 | $-1,061,784,173 |
| Interest Income Non Operating | $4,161,507 | $7,340,821 | $9,124,425 | $3,207,784 |
| Operating Income | $-33,210,915 | $7,426,229 | $-22,101,465 | $-156,136,567 |
| Depreciation Amortization Depletion Income Statement | $2,714,552 | $2,123,813 | $8,526,569 | $34,591,678 |
| Depreciation And Amortization In Income Statement | $2,714,552 | $2,123,813 | $8,526,569 | $34,591,678 |
| Gross Profit | $97,258,402 | $128,789,626 | $93,755,961 | $15,106,547 |
| Earnings From Equity Interest | - | - | - | $-208,538 |
| Per Share | ||||
| Diluted EPS | - | $0.03 | $-1.08 | $-56.87 |
| Basic EPS | - | $0.03 | $-1.08 | $-56.87 |
| Other | ||||
| Tax Effect Of Unusual Items | $-4,162,218 | $1,058,400 | $-185,893 | $-1,267,617 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-18,436,036 | $25,231,669 | $11,465,317 | $-88,067,074 |
| Total Unusual Items | $-10,405,546 | $7,802,736 | $-19,339,938 | $-1,018,427,495 |
| Total Unusual Items Excluding Goodwill | $-10,405,546 | $7,802,736 | $-19,339,938 | $-1,018,427,495 |
| Reconciled Depreciation | $10,100,924 | $8,970,691 | $23,327,070 | $66,660,973 |
| EBITDA (Bullshit earnings) | $-28,841,582 | $33,034,405 | $-7,874,621 | $-1,106,494,568 |
| EBIT | $-38,942,506 | $24,063,714 | $-31,201,691 | $-1,173,155,541 |
| Diluted NI Availto Com Stockholders | $-96,770,153 | $1,132,368 | $-49,341,646 | $-1,222,490,782 |
| Minority Interests | $0 | $0 | - | $252,665 |
| Tax Provision | $1,491,082 | $3,021,309 | $-394,300 | $-1,523,822 |
| Impairment Of Capital Assets | $11,359,981 | $495,367 | $26,261,548 | $1,037,933,267 |
| Gain On Sale Of Security | $954,435 | $8,298,103 | $8,030,491 | $43,356,678 |
| Research And Development | $2,862,593 | $2,616,333 | $2,542,313 | $7,394,201 |
| Selling General And Administration | $123,486,498 | $114,178,446 | $110,996,285 | $134,513,388 |
| Other Gand A | $75,847,319 | $64,997,651 | $64,999,075 | $80,576,789 |
| Salaries And Wages | $5,190,673 | $9,202,716 | $9,051,117 | $9,791,320 |
| Excise Taxes | $15,537,857 | $22,026,021 | $21,026,747 | $22,749,854 |
| Diluted Average Shares | - | $39,026,344 | $30,763,429 | $15,296,053 |
| Basic Average Shares | - | $39,026,344 | $30,763,429 | $15,296,053 |
| Gain On Sale Of Ppe | - | $354,443 | $824,188 | $265,477 |
| Other Special Charges | - | $-1,761,541 | $7,806,295 | $14,647,478 |
| Restructuring And Mergern Acquisition | - | $5,303,839 | $-5,873,226 | $5,569,316 |
| Write Off | - | - | $0 | $3,899,589 |
| Gain On Sale Of Business | - | - | - | $0 |
Fetched: 2026-07-16
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2022-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $322,942,022 | $340,306,187 | $338,602,297 | $420,739,206 |
| Total Assets | $427,813,838 | $606,871,076 | $596,911,787 | $771,772,643 |
| Total Non Current Assets | $144,933,168 | $266,428,947 | $293,282,658 | $241,444,961 |
| Other Non Current Assets | $2,575,052 | $5,496,007 | $8,560,732 | $2,241,961 |
| Non Current Deferred Assets | $1,749,441 | $3,002,804 | $10,920,129 | $0 |
| Non Current Deferred Taxes Assets | $1,749,441 | $3,002,804 | $10,920,129 | $0 |
| Non Current Accounts Receivable | $2,608,504 | $3,740,872 | $4,514,526 | $3,155,827 |
| Goodwill And Other Intangible Assets | $41,346,031 | $63,368,493 | $59,806,978 | $50,316,721 |
| Other Intangible Assets | $22,377,617 | $32,144,026 | $29,074,319 | $50,316,721 |
| Current Assets | $282,880,670 | $340,442,129 | $303,629,129 | $530,327,682 |
| Other Current Assets | $7,914,478 | $7,982,093 | $6,691,720 | $4,654,026 |
| Assets Held For Sale Current | $1,413,503 | $158,005 | $995,715 | $43,768,060 |
| Restricted Cash | $34,014,462 | $33,741,157 | $30,694,225 | $36,278,487 |
| Inventory | $124,606,767 | $170,170,531 | $132,650,069 | $99,589,330 |
| Receivables | $31,727,662 | $30,227,328 | $32,320,536 | $33,488,491 |
| Other Receivables | $1,859,760 | $3,106,717 | $2,390,002 | $10,813,369 |
| Taxes Receivable | $0 | $2,197,122 | $1,075,430 | $2,273,277 |
| Accounts Receivable | $29,867,902 | $24,923,489 | $28,855,105 | $20,401,845 |
| Cash Cash Equivalents And Short Term Investments | $83,203,798 | $98,163,015 | $99,735,947 | $312,549,287 |
| Cash And Cash Equivalents | $46,042,049 | $98,163,015 | $96,863,390 | $311,601,970 |
| Hedging Assets Current | - | $0 | $540,918 | - |
| Financial Assets | - | - | $0 | $18,706,495 |
| Non Current Prepaid Assets | - | - | - | $2,230,573 |
| Non Current Note Receivables | - | - | - | $11,388 |
| Prepaid Assets | - | - | - | $4,654,026 |
| Debt | ||||
| Total Debt | $16,981,253 | $74,435,239 | $74,583,280 | $191,805,810 |
| Long Term Debt And Capital Lease Obligation | $12,903,731 | $55,293,875 | $33,860,016 | $168,315,753 |
| Current Debt And Capital Lease Obligation | $4,077,522 | $19,141,365 | $40,723,264 | $23,490,057 |
| Long Term Debt | - | $28,607,422 | $3,486,071 | $142,097,621 |
| Current Debt | - | $15,311,526 | $37,267,085 | $19,112,895 |
| Other Current Borrowings | - | $15,311,526 | $37,267,085 | $19,112,895 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $63,525,786 | $173,716,388 | $168,540,661 | $300,353,020 |
| Total Non Current Liabilities Net Minority Interest | $15,889,454 | $94,811,462 | $79,844,415 | $207,217,691 |
| Other Non Current Liabilities | $354,443 | $34,230,829 | $32,818,038 | $91,102 |
| Derivative Product Liabilities | $2,631,279 | $3,936,599 | $1,643,393 | $26,545,530 |
| Non Current Deferred Liabilities | $0 | $1,350,159 | $11,522,968 | $2,036,982 |
| Non Current Deferred Taxes Liabilities | $0 | $1,350,159 | $11,522,968 | $2,036,982 |
| Current Liabilities | $47,636,333 | $78,904,927 | $88,696,246 | $93,135,329 |
| Current Deferred Liabilities | $903,902 | $764,402 | $1,200,695 | $2,740,175 |
| Payables And Accrued Expenses | $40,960,983 | $57,797,042 | $42,782,309 | $49,850,536 |
| Payables | $13,738,594 | $26,855,845 | $17,449,574 | $11,658,197 |
| Total Tax Payable | $7,112,354 | $7,197,762 | $2,880,386 | $802,124 |
| Income Tax Payable | $4,952,954 | $5,409,887 | $1,101,052 | $118,860 |
| Accounts Payable | $6,626,240 | $19,658,083 | $14,465,986 | $9,863,205 |
| Other Payable | - | $20,640 | $103,201 | $992,868 |
| Tradeand Other Payables Non Current | - | - | $0 | $10,228,324 |
| Other Current Liabilities | - | - | - | $13,204,082 |
| Equity | ||||
| Common Stock Equity | $364,288,052 | $403,674,680 | $398,409,275 | $471,055,927 |
| Total Equity Gross Minority Interest | $364,288,052 | $433,154,688 | $428,371,126 | $471,419,623 |
| Stockholders Equity | $364,288,052 | $403,674,680 | $398,409,275 | $471,055,927 |
| Gains Losses Not Affecting Retained Earnings | $-38,067,785 | $-40,026,476 | $-31,107,742 | $-38,795,177 |
| Other Equity Adjustments | $-38,067,785 | $-40,026,476 | $-31,107,742 | $-38,795,177 |
| Retained Earnings | $-4,584,922,629 | $-4,532,138,327 | $-4,532,274,269 | $-4,297,643,445 |
| Long Term Equity Investment | $8,621,230 | $0 | - | $859,063 |
| Other | ||||
| Ordinary Shares Number | $41,954,985 | $40,023,794 | $38,822,079 | $21,193,451 |
| Share Issued | $41,954,985 | $40,023,794 | $38,822,079 | $21,193,451 |
| Tangible Book Value | $322,942,022 | $340,306,187 | $338,602,297 | $420,739,206 |
| Invested Capital | $364,288,052 | $447,593,628 | $439,162,431 | $632,266,444 |
| Working Capital | $235,244,338 | $261,537,202 | $214,932,883 | $437,192,353 |
| Capital Lease Obligations | $16,981,253 | $30,516,292 | $33,830,123 | $30,595,294 |
| Total Capitalization | $364,288,052 | $432,282,102 | $401,895,346 | $613,153,549 |
| Minority Interest | $0 | $29,480,007 | $29,961,851 | $363,696 |
| Capital Stock | $4,987,278,467 | $4,975,839,484 | $4,961,791,286 | $4,807,494,550 |
| Common Stock | $4,987,278,467 | $4,975,839,484 | $4,961,791,286 | $4,807,494,550 |
| Long Term Capital Lease Obligation | $12,903,731 | $26,686,453 | $30,373,945 | $26,218,132 |
| Current Deferred Revenue | $903,902 | $764,402 | $1,200,695 | $2,740,175 |
| Current Capital Lease Obligation | $4,077,522 | $3,829,839 | $3,456,179 | $4,377,162 |
| Current Provisions | $1,693,926 | $1,202,118 | $3,989,979 | $3,850,479 |
| Current Accrued Expenses | $27,222,388 | $30,941,197 | $25,332,735 | $38,192,339 |
| Investments And Advances | $8,621,230 | $0 | - | $859,063 |
| Goodwill | $18,968,413 | $31,224,467 | $30,732,659 | $0 |
| Net PPE | $88,032,910 | $190,820,771 | $209,480,292 | $166,164,894 |
| Accumulated Depreciation | $-120,111,457 | $-207,588,504 | $-190,516,149 | $-338,714,039 |
| Gross PPE | $208,144,368 | $398,409,275 | $399,996,441 | $504,878,934 |
| Construction In Progress | $12,429,716 | $19,325,704 | $18,739,947 | $24,383,995 |
| Other Properties | $61,888,087 | $112,362,813 | $113,401,944 | $123,781,868 |
| Machinery Furniture Equipment | $20,195,442 | $28,168,282 | $27,923,446 | $29,904,912 |
| Buildings And Improvements | $103,636,959 | $197,676,901 | $198,790,053 | $311,296,636 |
| Land And Improvements | $9,994,164 | $40,875,575 | $41,141,051 | $15,511,523 |
| Properties | $0 | $0 | $0 | $0 |
| Other Inventories | $14,386,272 | $36,417,987 | $30,443,695 | $16,958,477 |
| Finished Goods | $24,727,762 | $48,054,120 | $40,580,917 | $15,497,288 |
| Work In Process | $82,146,873 | $77,583,237 | $50,958,705 | $59,434,741 |
| Raw Materials | $3,345,860 | $8,115,187 | $10,666,752 | $7,698,823 |
| Other Short Term Investments | $37,161,749 | $0 | $2,872,557 | $947,317 |
| Leases | - | - | - | - |
Fetched: 2026-07-16
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2022-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-25,662,268 | $677,570 | $-60,740,772 | $-101,407,809 |
| Operating Activities | ||||
| Operating Cash Flow | $-9,616,233 | $11,392,009 | $-48,759,448 | $-78,480,733 |
| Cash From Discontinued Operating Activities | $-4,044,782 | $-2,108,867 | $-3,802,081 | $0 |
| Cash Flow From Continuing Operating Activities | $-5,571,451 | $13,500,875 | $-44,957,367 | $-78,480,733 |
| Operating Gains Losses | $-1,108,881 | $-8,205,577 | $121,706 | $-1,362,970 |
| Investing Activities | ||||
| Capital Expenditure | $-16,046,035 | $-10,714,438 | $-11,981,324 | $-22,927,076 |
| Investing Cash Flow | $-51,678,268 | $-10,197,720 | $-2,393,560 | $-25,744,117 |
| Cash From Discontinued Investing Activities | $167,257 | $-1,750,865 | $-268,324 | $0 |
| Cash Flow From Continuing Investing Activities | $-51,845,525 | $-8,446,855 | $-2,125,237 | $-25,744,117 |
| Net Other Investing Changes | $582,198 | $-3,048,355 | $1,511,722 | $-131,671 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $7,762,167 | $0 | $26,991,787 | $249,240,580 |
| Financing Cash Flow | $6,947,232 | $-82,561 | $-34,108,411 | $105,179,286 |
| Cash From Discontinued Financing Activities | $3,462,584 | $3,063,302 | $-338,073 | $0 |
| Cash Flow From Continuing Financing Activities | $3,484,648 | $-3,145,863 | $-33,770,338 | $105,179,286 |
| Net Other Financing Charges | $-1,123,116 | - | - | $-22,475,125 |
| Net Common Stock Issuance | $7,762,167 | $0 | $26,991,787 | $249,240,580 |
| Common Stock Issuance | $7,762,167 | $0 | $26,991,787 | $249,240,580 |
| Other | ||||
| Repayment Of Debt | $-3,572,191 | $-3,729,484 | $-71,113,578 | $-121,586,169 |
| Interest Paid Supplemental Data | $1,676,133 | $2,080,397 | $10,581,344 | $19,732,815 |
| Income Tax Paid Supplemental Data | $540,206 | $660,489 | $0 | - |
| End Cash Position | $46,042,049 | $98,163,015 | $96,863,390 | $311,601,970 |
| Beginning Cash Position | $98,163,015 | $96,863,390 | $181,913,425 | $299,965,125 |
| Effect Of Exchange Rate Changes | $2,226,303 | $187,898 | $211,385 | $10,682,410 |
| Changes In Cash | $-54,347,269 | $1,111,728 | $-85,261,420 | $954,435 |
| Proceeds From Stock Option Exercised | $417,788 | $583,622 | $0 | - |
| Net Issuance Payments Of Debt | $-3,572,191 | $-3,729,484 | $-60,762,124 | $-121,586,169 |
| Net Long Term Debt Issuance | $-3,572,191 | $-3,729,484 | $-60,762,124 | $-121,586,169 |
| Long Term Debt Payments | $-3,572,191 | $-3,729,484 | $-71,113,578 | $-121,586,169 |
| Net Investment Purchase And Sale | $-37,161,749 | $3,905,994 | $3,553,686 | $0 |
| Sale Of Investment | $0 | $3,905,994 | $3,553,686 | $0 |
| Purchase Of Investment | $-37,161,749 | $0 | - | $0 |
| Net PPE Purchase And Sale | $-15,265,975 | $-9,304,494 | $-3,244,082 | $-8,942,933 |
| Sale Of PPE | $780,060 | $1,409,944 | $8,737,242 | $13,984,143 |
| Purchase Of PPE | $-16,046,035 | $-10,714,438 | $-11,981,324 | $-22,927,076 |
| Change In Working Capital | $-6,557,914 | $10,110,176 | $-11,061,052 | $37,474,200 |
| Change In Other Working Capital | $348,749 | $-822,052 | $76,867 | $1,348,024 |
| Change In Payables And Accrued Expense | $-5,858,280 | $10,677,428 | $-10,300,209 | $5,050,462 |
| Change In Payable | $-5,858,280 | $10,677,428 | $-10,300,209 | $5,050,462 |
| Change In Account Payable | $-5,725,185 | $5,074,661 | $-11,175,642 | $4,814,878 |
| Change In Tax Payable | $-133,094 | $5,602,767 | $875,432 | $235,584 |
| Change In Income Tax Payable | $-133,094 | $5,602,767 | $875,432 | $235,584 |
| Change In Prepaid Assets | $-543,053 | $-1,281,121 | $-390,030 | $1,903,887 |
| Change In Inventory | $5,294,587 | $-1,437,702 | $2,755,833 | $14,994,804 |
| Change In Receivables | $-5,799,917 | $2,973,623 | $-3,203,513 | $13,049,636 |
| Changes In Account Receivables | $-5,799,917 | $2,973,623 | $-3,203,513 | $13,049,636 |
| Other Non Cash Items | $17,125,735 | $-23,080,810 | $-50,843,404 | $-16,052,441 |
| Stock Based Compensation | $5,190,673 | $8,202,018 | $9,051,117 | $9,791,320 |
| Asset Impairment Charge | $11,359,981 | $495,367 | $26,261,548 | $1,049,312,464 |
| Deferred Tax | $39,145 | $-2,243,384 | $-1,186,460 | $-1,560,832 |
| Deferred Income Tax | $39,145 | $-2,243,384 | $-1,186,460 | $-1,560,832 |
| Depreciation Amortization Depletion | $10,100,924 | $8,970,691 | $23,327,070 | $66,660,973 |
| Depreciation And Amortization | $10,100,924 | $8,970,691 | $23,327,070 | $66,660,973 |
| Amortization Cash Flow | $575,081 | $224,196 | $641,272 | $23,833,113 |
| Amortization Of Intangibles | $575,081 | $224,196 | $641,272 | $23,833,113 |
| Depreciation | $9,525,843 | $8,746,495 | $22,685,798 | $42,827,860 |
| Net Foreign Currency Exchange Gain Loss | $-1,108,881 | $-8,205,577 | $121,706 | $-1,362,970 |
| Net Income From Continuing Operations | $-41,721,114 | $19,252,395 | $-40,627,891 | $-1,222,743,447 |
| Issuance Of Debt | - | $8,313,049 | $10,351,454 | $0 |
| Long Term Debt Issuance | - | $8,313,049 | $10,351,454 | $0 |
| Net Business Purchase And Sale | - | $0 | $-3,946,563 | $-16,669,514 |
| Purchase Of Business | - | $0 | $-3,946,563 | $-16,669,514 |
| Other Cash Adjustment Outside Changein Cash | - | - | $83,985 | - |
| Change In Other Current Liabilities | - | - | $-17,793 | $1,127,386 |
| Sale Of Business | - | - | - | - |
Fetched: 2026-07-16